Maxona Pharmaceuticals

About:

Maxona is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.

Website: https://maxonapharm.com

Description:

Maxona is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain. It is developing MAX-001 as the first novel therapeutic alternative to opioids and NSAIDs for the treatment of pain. While the U.S. is currently experiencing an opioid abuse epidemic, there has been very limited innovation to address the needs of millions of Americans suffering from acute and chronic pain. Hence, there is a significant need for safe and efficacious alternative analgesics. MAX-001 is an ex-US marketed non-opioid, non-NSAID analgesic New Molecular Entity that aims to fundamentally address the shortcomings of existing therapies. The company was founded in 2015 and is based in King of Prussia, Pennsylvania.

Total Funding Amount:

$15.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

King Of Prussia, Pennsylvania, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)maxonapharm.com

Founders:

Shawn Fatholahi

Number of Employees:

1-10

Last Funding Date:

2021-05-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai